Impact of different palliative systemic treatments on skeletal muscle mass in metastatic colorectal cancer patients

Impact of different palliative systemic treatments on skeletal muscle mass in metastatic colorectal cancer patients

Abstract Background Observational studies suggest that loss of skeletal muscle mass (SMM) is associated with chemotherapy‐related toxicity, poor quality of life, and poor survival in metastatic colorectal cancer (mCRC) patients. Little is known about the evolution of SMM during palliative systemic t...

Full description

Bibliographic Details
Main Authors: Sophie A. Kurk, Petra H.M. Peeters, Bram Dorresteijn, Pim A. deJong, Marion Jourdan, Hugo J. Kuijf, Cornelis J.A. Punt, Miriam Koopman, Anne M. May
Format: Article
Language:English
Published: Wiley 2018-10-01
Series:Journal of Cachexia, Sarcopenia and Muscle
Subjects:
Metastatic colorectal cancer
Skeletal muscle
Sarcopenia
Body composition
Chemotherapy
Online Access:https://doi.org/10.1002/jcsm.12337

Internet

https://doi.org/10.1002/jcsm.12337

Similar Items